on Revolune
Revolune and MindPeak Collaborate for AACR 2026 Showcase
Revolune GmbH and MindPeak are set to present an integrated workflow at the AACR Annual Meeting 2026, combining multiplex immunofluorescence (mIF) reagents with AI-powered image analysis. This collaboration aims to simplify spatial biology workflows that are crucial for understanding tumor biology and biomarker context.
The integrated approach merges Revolune's advanced mIF reagents and MindPeak's AI-driven software to facilitate the generation of high-quality multiplex tissue data. This offers a streamlined process for researchers, from staining to actionable biological insights.
"Bridging the gap in spatial biology requires robust workflow and data analysis," said Florian Leiss, CEO of Revolune. MindPeak's CEO, Felix Faber, echoed this sentiment, highlighting the reduced barriers to workflow adoption.
Attendees of AACR 2026 can visit booth 1660 to learn about these advancements and their implications for cancer research.
R. E.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Revolune news